Skip to main content
Premium Trial:

Request an Annual Quote

ARUP Labs Adopts Affymetrix's CytoScan HD for Testing Service


By Justin Petrone

ARUP Laboratories is now offering constitutional genetic testing on Affymetrix's CytoScan HD Array platform.

The Salt Lake City-based reference lab said this week that the CytoScan HD can be ordered for the following indications: autism spectrum disorder; intellectual disabilities; multiple congenital anomalies with or without dysmorphic features; identification of long contiguous stretches of homozygosity that may be suggestive of uniparental disomy or increased risk of a recessive disorder; to characterize previously identified cytogenetic abnormalities such as unbalanced rearrangements, duplications, deletions, or ring and marker chromosomes, and analysis of apparently balanced rearrangements in individuals with an abnormal phenotype.

ARUP President and CEO Edward Ashwood said in a statement that the reference lab is "pleased" with CytoScan HD's "accuracy and performance." He said the adoption of the new array was part of the lab's goal of providing "high-quality genetic testing."

Affy launched its CytoScan HD Array last month. The chip includes more than 2.6 million copy number markers, of which 750,000 are genotypeable SNPs and 1.9 million are non-polymorphic probes. The Santa Clara, Calif.-based vendor claims the array enables accurate breakpoint estimation, high-resolution loss of heterozygosity determination, detection of uniparental isodisomy and regions identical-by-descent, as well as low-level mosaicism visualization and heterogeneity measurements (BAN 7/26/2011).

The addition of CytoScan HD complements ARUP's current array-based cytogenetic testing menu. The lab also offers its internally designed UArray, which is used for comparative genomic hybridization and is manufactured by Agilent Technologies. ARUP also offers array CGH-based prenatal screening, although it does not disclose the manufacturer on its website. A high-density array focused on the X chromosome is also available. The 720,000-probe CGH chip is manufactured by Roche NimbleGen.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.